Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedXV
XTX Ventures
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $70M 2 disclosed · full round size, not this investor’s share